This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated ATR Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-ATR WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~301.4 kDa | |
| Observed band | ~301 kDa | |
| Gel | 4–12% gradient | |
| Negative control | siRNA / KO lysate |
| PTM | Phosphorylated | |
| Caveat | Alternative splicing isoforms | |
| Regulation | Upregulated (immune signature) | |
| Isoform | 3 isoform(s) |
Literature-validated Western blot parameters for ATR — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human Hela , Lane 2: human Daudi . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-ATR antigen affinity purified polyclonal antibody (Catalog # A00262-3) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for ATR at approximately 301 kDa. The expected band size for ATR is at 301 kDa |
| Gel % | 4–12% gradient |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 301 kDa |
ATR has a 301.4 kDa predicted mass and runs at the empirically observed ~301 kDa, with heavy phosphorylation as the main source of minor mobility shifts.
| single band at ~301 kDa | matches the 301.4 kDa predicted mass of full-length ATR with no major shifting modification |
| band sitting slightly above the unmodified 301 kDa backbone | multiple phosphorylation sites, including autophosphorylated Thr1989, add mass and can retard migration slightly |
| faint extra bands distinct from the main ~301 kDa band | ATR has three annotated splice isoforms that can migrate at different apparent sizes if co-expressed |
| no doubling of band size under standard reducing SDS-PAGE | ATR-ATRIP is a non-covalent heterodimer, not disulfide-linked, so it dissociates under reducing and denaturing conditions |
| band still detected in whole-cell lysate rather than only a nuclear fraction | ATR is nuclear and chromosome-associated, but whole-cell lysis captures the nuclear compartment along with the rest of the cell |
| Predicted mass (301.4 kDa) | sets the baseline expected migration for this very large kinase, requiring low-percentage gels and extended run and transfer times |
| Phosphorylation at Ser428, Ser435, Ser436, and autocatalytic Thr1989 | can cause the observed band to run slightly higher than the unmodified 301 kDa backbone |
| Alternative splice isoforms 1, 2, and 3 | isoform 2 or 3 may appear as additional bands of somewhat different apparent size relative to the canonical isoform 1 band |
| ATR-ATRIP heterodimer formation | is a non-covalent association that dissociates under reducing, denaturing SDS-PAGE, so it does not add mass to the detected band |
| Absence of signal peptide or propeptide cleavage | means no smaller mature or cleaved form is expected; the full-length translated product is what is detected |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | ATR is a large, low-abundance nuclear and chromatin-bound protein that can be under-extracted by insufficient lysis | use a nuclear extraction or high-salt lysis buffer with sonication and load a higher amount of total protein |
| Band higher than expected | extensive phosphorylation, including autophosphorylation at Thr1989, retards migration relative to the unmodified backbone | treat a parallel lysate aliquot with lambda phosphatase and compare mobility to confirm a phospho-dependent shift |
| Weak or no signal | ATR is both very large and typically low in cellular abundance, which reduces transfer efficiency and detectable signal | use a low-percentage gel, extend wet transfer time, and increase total protein loaded per lane |
| Multiple bands | the three annotated splice isoforms of ATR can each produce a band of somewhat different apparent size | check which isoform the antibody epitope falls within and confirm band identity against isoform-specific sequence differences |
| Fragments below expected size | a protein of this size is prone to proteolytic degradation during lysis if protease activity is not adequately controlled | keep samples cold, add fresh protease inhibitor cocktail, and minimize freeze-thaw cycles before loading |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for ATR, answered from its protein features.
BosterBio's ATR antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Boster's anti-ATR antibody A00262-3 is a best-performing, thoroughly validated reagent for ATR Western blotting, widely cited in the literature and orthogonally cross-validated against negative tissue and complementary detection methods to ensure specificity and reliable results.
Which to pick: Only one ATR antibody is catalogued, A00262-3, which includes an actual Western blot validation image—making it the clear, ready-to-use choice for ATR WB experiments without needing to compare alternatives.